Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

Samson, A, Scott, KJ orcid.org/0000-0002-5790-9579, Taggart, D et al. (36 more authors) (2018) Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science Translational Medicine, 10 (422). eaam7577. ISSN 1946-6234

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. This is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science Translational Medicine on 3 January 2018, DOI: 10.1126/scitranslmed.aam7577.
Dates:
  • Published: 3 January 2018
  • Accepted: 27 November 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP)
Funding Information:
FunderGrant number
Brain Tumour Charity13/192
Depositing User: Symplectic Publications
Date Deposited: 05 Dec 2017 15:44
Last Modified: 13 Mar 2019 15:15
Status: Published
Publisher: American Association for the Advancement of Science
Identification Number: https://doi.org/10.1126/scitranslmed.aam7577

Share / Export

Statistics